Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-05-06
2008-05-06
Chernyshev, Olga N. (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007800, C435S007920, C435S040500, C436S501000, C436S503000, C436S504000
Reexamination Certificate
active
07368253
ABSTRACT:
Markers for TSE that are present prior to formation of detectable pathological prion protein are useful to detect this infection prior to clinical signs. Additional markers are useful to detect the stage of TSE infection and distinguish it from other conditions which have similar clinical symptoms. Determinations on isolated cell preparations are particularly useful, especially those derived from peripheral (non-brain) sources.
REFERENCES:
J. Virology, 2002, 76, No. 21, pp. 10905-10913.
Lin et al., 2001, J. Biol. Chem, vol. 276, No. 45, pp. 42077-42083.
Ishida et al., 1994, J. Leukocyte Biol., vol. 54, pp. 797-806.
Ferreira et al., 1999, J. Leukocyte Biol., vol. 66, 593-600.
Hashimoto et al., Blood (2000) 96:2206-2214.
Manuelidis et al., Lancet (1985) 2:896-897.
Manuelidis et al., Science (1978) 200:1069-1071.
Internaional Search Report for PCT/US05/07189, mailed on Jan. 31, 2006, 2 pages.
Mabbott et al., J. Virology (2002) 76(10):5131-5139.
Starke et al., 43rd Annual Meeting of American Society of Hematology (2001) 98(11):247a-248a.
Arjona et al., PNAS USA (2004) 101:8768-8773.
Baker and Manuelidis, PNAS USA (2003) 100:675-679.
Baker et al., J. Neurovirol. (2004) 10:29-40.
Baker et al., J. Virol. (2002) 76:10905-10913.
Harrison et al., PNAS USA (1998) 95:10896-10901.
Lu et al., J. Cell. Biochem. (2004) 93:644-652.
Manuelidis and Lu, Neurosci. Lett. (2000) 293:163-166.
Manuelidis and Lu, PNAS USA (2003) 100:5360-5365.
Manuelidis et al., Science (1997) 277:94-98.
Manuelidis, Viral Immunol. (2003) 16:123-139.
Radebold et al., BMC Infectious Diseases (2001) 1:20.
Chernyshev Olga N.
Morrison & Foerster / LLP
LandOfFree
Pre-symptomatic markers for diseases associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pre-symptomatic markers for diseases associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pre-symptomatic markers for diseases associated with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2803330